In Vivo Insulin Sensitivity and Secretion in Obese Youth
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Impaired glucose tolerance (IGT) represents a pre-diabetic state. Controversy continues in regards to its pathophysiology. The aim of this study was to investigate the differences in insulin sensitivity (IS) and secretion in obese adolescents with IGT compared with those with normal glucose tolerance (NGT) and type 2 diabetes. RESEARCH DESIGN AND METHODS—A total of 12 obese adolescents with NGT, 19 with IGT, and 17 with type 2 diabetes underwent evaluation of insulin sensitivity (3-h hyperinsulinemic [80mu/m2/min]–euglycemic clamp), first-phase insulin and second-phase insulin secretion (2-h hyperglycemic clamp), body composition, and abdominal adiposity. Glucose disposition index (GDI) was calculated as the product of first-phase insulin × insulin sensitivity. RESULTS—Insulin-stimulated glucose disposal was significantly lower in subjects with type 2 diabetes compared with subjects with NGT and IGT, with no difference between the latter two. However, compared with youth with NGT, youth with IGT have significantly lower first-phase insulin and C-peptide levels and GDI (P = 0.012), whereas youth with type 2 diabetes have an additional defect in second-phase insulin. Fasting and 2-h glucose correlated with GDI (r = −0.68, P < 0.001 and r = −0.73, P < 0.001, respectively) and first-phase insulin but not with insulin sensitivity. CONCLUSIONS—Compared with youth with NGT, obese adolescents with IGT have evidence of a β-cell defect manifested in impaired first-phase insulin secretion, with a more profound defect in type 2 diabetes involving both first- and second-phase insulin. GDI shows a significantly declining pattern: it is highest in NGT, intermediate in IGT, and lowest in type 2 diabetes. Such data suggest that measures to prevent progression or conversion from pre-diabetes to type 2 diabetes should target improvement in β-cell function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“However, youth with IGT are no more insulin resistant than peers with normal glucose tolerance (NGT) if matched for body composition and fat topography ( 51 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · cited 2×
“5% in children recruited from the community (3,4) up to 25% in youth from an obesity clinic (5).”
BackgroundResultGillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171 · cited 1×
“ported in many randomized control trials, with lifestyle intervention being at least as effective if not more effective than pharmacotherapy (16).”
BackgroundEdelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.701 · Cited by 641 · cited 2×
“Impaired glucose tolerance is a well known prediabetic state with a linear relationship between the 2hr post challenge glucose levels and subsequent risk for T2DM in adult prospective studies (1) with observed rates of progression from IGT to T2DM from 20% (13) to 60% (14,15) over an average duration of 2 to 8 years (…”
BackgroundEdelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffner, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.4.701 · Cited by 641
Diabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
Knowler, W. C., Pettitt, D. J., Saad, M. F., & Bennett, P. H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060101 · Cited by 578 · cited 1×
“Impaired glucose tolerance is a well known prediabetic state with a linear relationship between the 2hr post challenge glucose levels and subsequent risk for T2DM in adult prospective studies (1) with observed rates of progression from IGT to T2DM from 20% (13) to 60% (14,15) over an average duration of 2 to 8 years (…”
BackgroundFerrannini, E., Gastaldelli, A., Miyazaki, Y., Matsuda, M., Mari, A., & DeFronzo, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1133 · Cited by 540
Weiss, R., Dufour, S., Taksali, S. E., Tamborlane, W. V., Petersen, K. F., Bonadonna, R. C., Boselli, L., Barbetta, G., Allen, K., Rife, F., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14364-4 · Cited by 499 · cited 1×
“Higher insulin resistance, measured by the hyperinsulinemic-euglycemic clamp method, was reported in adolescents with IGT compared to NGT controls with no significant differences in insulin secretion (19).”
MethodThe natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413 · cited 1×
“Impaired glucose tolerance is a well known prediabetic state with a linear relationship between the 2hr post challenge glucose levels and subsequent risk for T2DM in adult prospective studies (1) with observed rates of progression from IGT to T2DM from 20% (13) to 60% (14,15) over an average duration of 2 to 8 years (…”
BackgroundPredictors of Changes in Glucose Tolerance Status in Obese Youth
Weiss, R., Taksali, S. E., Tamborlane, W. V., Burgert, T. S., Savoye, M., & Caprio, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.902 · Cited by 378 · cited 1×
“3 mpaired glucose tolerance (IGT) is a condition of altered glucose homeostasis associated with a high risk of progression to T2DM in adults (1) and children (2).”
BackgroundHaffner, S. M., Miettinen, H., Gaskill, S. P., & Stern, M. P. (1995) · Diabetes · doi:10.2337/diab.44.12.1386 · Cited by 303
Weyer, C., Bogardus, C., & Pratley, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2197 · Cited by 292
Bacha, F., Saad, R., Gungor, N., & Arslanian, S. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.2.547 · Cited by 278 · cited 12×
“5 mmol/l) as previously described (11).”
BackgroundMethodSelf-citationThe Natural Course of β-Cell Function in Nondiabetic and Diabetic Individuals
Festa, A., Williams, K., D’Agostino, R., Wagenknecht, L. E., & Haffner, S. M. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1100 · Cited by 271 · cited 3×
“Our current findings are consistent with data in adults with IGT, where longitudinal studies point to the deterioration in insulin secretion relative to insulin sensitivity in the transition from NGT to IGT to type 2 diabetes (8).”
BackgroundResultArslanian, S. A., Lewy, V. D., & Danadian, K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7123 · Cited by 268 · cited 4×
“Lastly, the current findings confirm our previous observations in PCOS girls (9).”
ResultSelf-citationGoran, M. I., Bergman, R. N., Avila, Q., Watkins, M., Ball, G. D. C., Shaibi, G. Q., Weigensberg, M. J., & Cruz, M. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031402 · Cited by 236
METHODS AND PREVALENCE OF NON-INSULIN-DEPENDENT DIABETES MELLITUS IN A BIETHNIC COLORADO POPULATION
HAMMAN, R. F., MARSHALL, J. A., BAXTER, J., KAHN, L. B., MAYER, E. J., ORLEANS, M., MURPHY, J. R., & LEZOTT, D. C. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115134 · Cited by 218 · cited 1×
“Impaired glucose tolerance is a well known prediabetic state with a linear relationship between the 2hr post challenge glucose levels and subsequent risk for T2DM in adult prospective studies (1) with observed rates of progression from IGT to T2DM from 20% (13) to 60% (14,15) over an average duration of 2 to 8 years (…”
BackgroundGungor, N., Bacha, F., Saad, R., Janosky, J., & Arslanian, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.638 · Cited by 186
Self-citationFesta, A., D’Agostino, R., Hanley, A. J. G., Karter, A. J., Saad, M. F., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1549 · Cited by 180 · cited 1×
“These findings are in agreement with our findings in girls with PCOS (9) and with the adult literature in terms of the determinants of the glycemic status in subjects with IGT, although all the variables were not measured simultaneously in these subjects (24,25).”
Resultβ-Cell Function Across the Spectrum of Glucose Tolerance in Obese Youth
Weiss, R., Caprio, S., Trombetta, M., Taksali, S. E., Tamborlane, W. V., & Bonadonna, R. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1735 · Cited by 164
Bacha, F., Saad, R., Gungor, N., & Arslanian, S. A. (2006) · Diabetes Care · doi:10.2337/dc06-0581 · Cited by 127
Self-citationMetabolic Abnormalities Underlying the Different Prediabetic Phenotypes in Obese Adolescents
Cali', A. M. G., Bonadonna, R. C., Trombetta, M., Weiss, R., & Caprio, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1722 · Cited by 124 · cited 1×
“Also, recently, they reported decreased glucose sensitivity of first-phase insulin secretion in subjects with IGT compared with those with NGT, which was consistent with our findings (22).”
ResultHaffner, S. M., Miettinen, H., GASKILL, S. P., et al. (1995) · Diabetes · doi:10.2337/diabetes.44.12.1386 · Cited by 104
Ethnic differences in beta cell adaptation to insulin resistance in obese children and adolescents
Weiss, R., Dziura, J. D., Burgert, T. S., Taksali, S. E., Tamborlane, W. V., & Caprio, S. (2006) · Diabetologia · doi:10.1007/s00125-005-0109-z · Cited by 96 · cited 3×
“In another study, the same group reported that IGT is characterized by a decline in AIR based on OGTT data (20).”
BackgroundInfluentialArslanian, S. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.66 · Cited by 81
Self-citationImpaired Glucose Tolerance in Obese Children and Adolescents
Uwaifo, G. I., Elberg, J., & Yanovski, J. A. (2002) · New England Journal of Medicine · doi:10.1056/nejm200207253470414 · Cited by 36 · cited 1×
“5% in children recruited from the community (3,4) up to 25% in youth from an obesity clinic (5).”
Background
Research works printed but not linked: 1
- Invitti C, Gilardini L, Viberti G: Impaired glucose tolerance in obese children and adolescents. N Engl J Med 347:290–292, 2002 · DOI
Cited by
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
Insulin resistance in children: Consensus, perspective, and future directions
Levy-Marchal, C., Arslanian, S., Cutfield, W., Sinaiko, A., Druet, C., Marcovecchio, M. L., & Chiarelli, F. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1047 · Cited by 405
Self-citationDynamics of insulin secretion and the clinical implications for obesity and diabetes
Seino, S., Shibasaki, T., & Minami, K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45680 · Cited by 364
Arslanian, S., Bacha, F., Grey, M., Marcus, M. D., White, N. H., & Zeitler, P. (2018) · Diabetes Care · doi:10.2337/dci18-0052 · Cited by 349
Self-citationTODAY Study Group (2013) · Diabetes Care · doi:10.2337/dc12-2393 · Cited by 288
Metadata
- Authors
- Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A.
- Affiliations
- Children's Hospital of Pittsburgh (US)
- Anadolu Saglik Merkezi Gebze, Kocaeli, Turkey
- Corresponding author
- Bacha, Fida
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-01-01
- Volume
- 32
- Issue
- 1
- Pages
- 100-105
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2606839
- OpenAlex
- W2160471613
- Cited by
- 90
- References
- 25
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 2 · 2014: 7 · 2013: 4 · 2012: 11
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Pittsburgh Foundation
- Thrasher Research Fund
- U.S. Public Health Service (K24 HD01357, UL1 RR024153)
- National Center for Research Resources (MO-1-RR-00084, UL1RR024153, M01RR000084)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01‐HD27503, R01HD027503, K24HD001357, K24 HD 01357)
- Children's Hospital of Pittsburgh
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin sensitivity, insulin secretion, impaired glucose tolerance, type 2 diabetes, adolescent obesity, beta-cell dysfunction, first-phase insulin secretion, second-phase insulin secretion, prediabetes, hyperinsulinemic-euglycemic clamp, hyperglycemic clamp, C-peptide, body composition, abdominal fat
- MeSH terms
- Abdomen, Insulin Secretion, Adipose Tissue, Adolescent, C-Peptide, Diabetes Mellitus, Type 2, Estradiol, Female, Glucose, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Insulin, Male, Obesity, Reference Values, Viscera, Glucose Clamp Technique, Body Mass Index, Glucose Intolerance, Dehydroepiandrosterone Sulfate, Black People, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.